About Contact Us Careers

Blood Glucose Monitoring Devices Market Size and Forecast, by Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices); Modality (Wearable, Non-Wearable); Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes); Distribution Channel (Hospitals, Retail Sales, Homecare) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4606
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Outlook:

Blood Glucose Monitoring Devices Market size was over USD 19.71 billion in 2025 and is anticipated to cross USD 43.35 billion by 2035, growing at more than 8.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.

Blood Glucose Monitoring Devices Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the escalating number of people suffering from diabetes, which needs to be monitored constantly. For instance, in 2021, around 537 million people were diagnosed with diabetes across the globe, and it is expected to increase to 640 million by 2030 and around 783 million by 2045. Further, the growing awareness among people regarding diabetes prevention, followed by the surge in the geriatric population developing diabetes, is also estimated to spur the market growth throughout the projected time frame.

In addition to these, factors that are believed to fuel the market growth of blood glucose monitoring systems include the rise in the stances of obesity among individuals. Since, obesity leads to several kinds of health disorders and diabetes is one of them that affects obese people in a high ratio. Based on a report released by the World Health Organization (WHO) on March 2022, obesity affects more than one billion people globally, comprising 650 million adults, 340 million teenagers, and 39 million children. This figure is still rising. Additionally, the growing ratio of physical inactivity, followed by the family history and genetic mutation, and hormonal disorders can also cause an increased level of blood glucose. Therefore, all of these major factors are predicted to present a prominent expansion to the market’s growth over the projected period.

Key Blood Glucose Monitoring Devices Market Insights Summary:

  • Regional Highlights:

    • North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.
    • Asia Pacific market will achieve lucrative growth during the forecast timeline, driven by large diabetes patient pool and rising awareness about diabetes preventive care.

  • Segment Insights:

    • The self-monitoring devices segment in the blood glucose monitoring devices market is projected to secure the largest share by 2035, driven by the convenience of home use and innovative lancet technology.
    • The type 2 diabetes segment in the blood glucose monitoring devices market exhibits significant share, fueled by the rising prevalence of type 2 diabetes globally, forecast year 2035.

  • Key Growth Trends:

    • Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes
    • Rising Ubiquity of Diabetes

  • Major Challenges:

    • Lower Diagnosis & Treatment Rate of Diabetes
    • Low Reimbursement Policies for the Blood Glucose Monitoring System

  • Key Players: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.

Global Blood Glucose Monitoring Devices Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 19.71 billion
    • 2026 Market Size: USD 21.16 billion
    • Projected Market Size: USD 43.35 billion by 2035
    • Growth Forecasts: 8.2% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (38.8% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, Germany, Japan, United Kingdom
    • Emerging Countries: China, India, Brazil, Mexico, South Korea

    • Last updated on : 10 September, 2025

Growth Drivers

  • Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – Glucose monitoring system helps to monitor the diabetes at an earlier stage, so that the proper treatment can be given at right time such human insulin is generally used to control blood sugar level in people dealing with type 1 diabetes or type 2 diabetes. For instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.

  • Rising Ubiquity of Diabetes – For instance, in 2021, China, Mexico, India, the United States, and Brazil accounted for around 50% of the global diabetes population.
  • Increase in the Number of Patients with type-1 or Insulin-Dependent type-2 Diabetes – For instance, according to a report in 2021, it was evaluated that the incidence of type-1 diabetes was 149.5 per 1000 children and the global prevalence was around 9.8% among the total population.
  • Growing Investment in Diabetic Research Activities – In the United States, more than USD 860 million were invested in over 4,800 diabetes research projects over the last 70 years.
  • Increasing Access to Health Care and Health Expenditures - As per the data from the World Bank, 9.83% of the global GDP was spent on health expenditures in 2019.

Challenges

  • Lower Diagnosis & Treatment Rate of Diabetes – In developing and underdeveloped countries, a large proportion of people remain undiagnosed owing to a lack of awareness and associated costs. Moreover, lack of access to medical facilities and poor healthcare infrastructure are also major concerns for the lower treatment rates of diabetes in such regions. Therefore, this factor is estimated to hinder blood glucose monitoring devices market growth over the projected time frame.

  • Low Reimbursement Policies for the Blood Glucose Monitoring System
  • Inadequate Approach to Advanced Healthcare Infrastructure

Blood Glucose Monitoring Devices Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

8.2%

Base Year Market Size (2025)

USD 19.71 billion

Forecast Year Market Size (2035)

USD 43.35 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Blood Glucose Monitoring Devices Market Segmentation:

Product Segment Analysis

The global blood glucose monitoring devices market is segmented and analyzed for demand and supply by product into self-monitoring devices, and continuous glucose monitoring devices. Out of these two types of segments, the self-monitoring devices segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the ease of use provided by these devices as people can monitor their blood sugar levels through these devices in the comfort of their homes.  Further, the development of novel lancet devices with faster outcomes and less pain for the user is also anticipated to fuel market expansion. For instance, in November 2021, Intuity Medical, Inc., launched the POGO Automatic Monitor, an innovative automatic glucose monitoring device. It utilizes ten-test cartridges that include test strips and lancets instead of depending on separate test strips and lancets. At the touch of a button, the POGO Automatic instantly lances, gathers blood, and provides results in a few seconds.

Disease Type Segment Analysis

The global blood glucose monitoring devices market is also segmented and analyzed for demand and supply by disease type into type 1 diabetes, type 2 diabetes, and gestational diabetes. Amongst these three segments, the type 2 diabetes segment is expected to garner a significant share, backed by the rapidly surging prevalence of type 2 diabetes patients throughout the world. As per the World Health Organization report, type 2 diabetes accounts for more than 95% of all diabetes cases worldwide. This, as an outcome, is projected to generate numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

                     By Product

  • Self-Monitoring Devices

  • Continuous Glucose Monitoring Devices

                      By Modality

  • Wearable

  • Non-Wearable

                      By Disease Type

  • Type 1 Diabetes

  • Type 2 Diabetes

  • Gestational Diabetes

                     By Distribution Channel

  • Hospitals

  • Retail Sales

  • Homecare
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Blood Glucose Monitoring Devices Market Regional Analysis:

North American Market Insights

North America region is expected to account for more than 38.8% market share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices. For instance, it was estimated that around 32.2 million people in the United States, were suffering from diabetes in 2021. Further, the huge investment in research and development activities, along with the increasing adoption of technologically advanced devices, are some further factors that are anticipated to boost the market growth. In addition, the expanding per capita medical expenditure is also anticipated to drive the market growth further during the projected time frame.

APAC Market Insights

Further, the Asia Pacific blood glucose monitoring devices market is also estimated to display lucrative revenue by the end of 2035. The growth of the market can be attributed to the large pool of diabetes patients who have been dealing with insulin-dependent diabetes, along with the escalating ratio of aged people in the region. In addition to this, rising awareness about diabetes preventive care, followed by improving healthcare facilities are some more factors that are anticipated to drive the growth of the market in the region throughout the forecast period.

Blood Glucose Monitoring Devices Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Blood Glucose Monitoring Devices Market Players:

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Ascensia Diabetes Care Holdings AG
    • Dexcom, Inc.
    • NIPRO CORPORATION
    • Prodigy Diabetes Care, LLC
    • ACON Laboratories, Inc.
    • Insulet Corporation
    • Ypsomed AG
    • Terumo Corporation

Recent Developments

  • Abbott Laboratories announced new data from the Real-World Evidence of FreeStyle Libre study showing the use of freestyle libre, a continuous glucose monitoring system significantly reduced the rate of hospitalizations.

  • F. Hoffmann-La Roche Ltd launched the cobas pulse system, a connected professional blood glucose management solution that builds on its inheritance with Accu-Chek Inform II. Healthcare professionals working in a variety of care settings can use this handheld blood glucose management device to monitor the blood glucose levels of patients.

  • Report ID: 4606
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.

The global blood glucose monitoring devices market size was valued at around USD 19.71 billion in 2025 and is projected to grow at a CAGR of more than 8.2%, reaching USD 43.35 billion revenue by 2035.

North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.

Key players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.

Blood Glucose Monitoring Devices Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos